Company
arrivent
Accelerating the Global Development of Innovative Biopharmaceutical Products
Also known as ArriVent BioPharma, ArriVent BioPharma, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Newtown Square, Pennsylvania, United States
- Founded
- 2021
- Legal name
- ArriVent BioPharma, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
We are a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with difficult-to-treat diseases, beginning with cancers.
Funding snapshot
- Total raised
- $260MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $110M2022-12-16
Funding rounds
- Round, 2022
- $110M2022-12-16, SEC form D sold, 17 investors
- Round, 2021
- $150M2021-06-09, SEC form D sold, 10 investors
Products
- Other
- ARR-002
- Other
- firmonertinib
Loading relationship preview